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I. Introduction
dvances in cancer medicine have 
traditionally come from detailed 
understanding of biological pro-
cesses, later translated into therapeutic 
interventions, whose effectiveness is 
established by rigorous analysis of 
clinical trials. Over the last 
two decades the increasing 
throughput of data from 
microarray screening, spec-
tral imaging and longitudinal 
studies are turning the under-
standing of cancer pathology 
into as much a data-based as 
a biologically and clinically 
driven science, with potential to impact 
more strongly on evidence-based deci-
sion support moving towards personal-
ized medicine [1].
This article is not intended as a 
 comprehensive survey of data mining 
applications in cancer. Rather, it provides 
starting points for further, more targeted, 
literature searches, by embarking on a 
guided tour of computational intelli-
gence applications in cancer medicine, 
structured in increasing order of the 
physical scales of biological processes, as 
outlined in Table 1. 
II. Robust Clustering and 
Data Visualization
Over the last decade, cancer has become 
a data-intensive area of research, with 
accelerating developments in data- 
acquisition technologies and specific 
methodologies, for example, next-generation 
sequencing for monitoring genetic 
changes in tumor cells as they progress 
from normal to invasive [2]. 
The first step in unrav-
elling these  processes is 
the study of co-occur-
rences, leading to the 
identification of disease 
sub-types. This already has 
profound implications for the 
clinical management of patients, 
impacting on one of the most 
funda mental precepts of cancer med-
icine – the histological characterisation 
of malignancies. Currently this is over-
whelmingly done by measuring the dif-
ferentiation between cancerous cells and 
the original normal cells from which 
they have evolved, marking them as well 
to poorly differentiated, meaning that the 
changes are linked with good to poor 
prognosis. Yet it is becoming apparent that 
the metabolism of cells is a key factor in 
uncontrolled cell proliferation, with a 
potentially greater influence on disease 
progression than cell differentiation alone.
Clustering is the first line analysis 
methodology to mine data bases for use-
ful research hypotheses to take onto fur-
ther, more directed, study [3], [4]. From 
a mathematical perspective the objects of 
study, be they genes, patients, mode of 
action drugs or disease sub-types, are 
points in a multi-dimensional space 
where similarity is defined, typically 
trough a measure of the distance between 
object pairs. The main classes of cluster-
ing approaches used in data mining for 
cancer are partitional, creating a simple 
partition of the data, or hierarchical, which 
create a tree-structured hierarchy of the 
data. Partitional approaches form a very 
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TABLE 1 Overview of healthcare interventions across physiological scales.
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heterogeneous class, including techniques 
based on Global Optimization, Vector 
Quantization, Kernel functions, Fuzzy 
sets, and Graph theory [5]. Hierarchical 
approaches can be agglomerative or divisive 
and are often used as for first-line clus-
tering of high-throughput data. How-
ever, high- dimensional data spaces are 
by nature ultra-metric, each data point 
appearing to be at the centre of a hollow 
sphere, in contrast with the usual intui-
tive picture in low dimensions [6]. This 
effect needs to be taken into account 
especially with agglomerative methods 
to avoid early stage errors that can arise, 
resulting in sub-optimal solutions com-
pared with partition algorithms. A third 
main class of algorithms is biclustering 
that is to say clustering of both objects 
and features within a single model [7]. 
The range of clustering techniques illus-
trates the complexity of the problem. 
The fundamental concept underlying 
the definition of clusters, “similarity”, is 
complex in itself because of its ambigui-
ty. This difficulty is compounded when 
the most relevant features are not known 
a priori, yet the choice of different fea-
tures usually produces different solutions. 
An open research question is feature selec-
tion operating with unsupervised train-
ing. This will normally involve 
parametric modeling and the application 
of Bayesian methods to derive the dis-
criminative features which best separate 
between the clusters [8]. 
 In addition to such intrinsic complex-
ity, purely algorithmic issues may give 
rise to different solutions for the same 
data set, even for the same algorithm. 
This raises the possibility that cluster sta-
bilization methods including global stabil-
ity assessments [10], [11] and consensus 
clustering [12], [13] methods may miss the 
real complexity of the problem. 
An alternative approach to clustering 
assessment shifts the focus from the 
search of the best solution to the search 
of a set of equally plausible, though 
 different, solutions [14]. Recently, meta-
clustering [15] (see fig 1) has been pro-
posed as a clustering assessment tool. It is 
the process of clustering the solutions i.e., 
the cluster partitions themselves, general-
izing the concept of global  stability to 
local stability (see Fig. 1), that is, the sta-
bility of a solution with respect to a 
homogenous subset of the candidates.
The cluster composition then needs 
to be explored in detail, for which den-
drograms provide a useful representation, 
usually through sequential univariate 
splitting of the data space. However, the 
interpretation of geometrical relationships 
in the data is often best derived from 
direct spatial representations. The most 
commonly used methods for data visual-
ization are Multi Dimensional Scaling, 
Principal Component Analysis (PCA) 
and Self-Organizing Maps [16], [17]. 
Linear methods are particularly inter-
esting since they enable axes projections 
to be overlaid on the data. An efficient 
methodology for cluster-based linear 
visualization is to use a decomposition of 
the covariance matrix which explicitly 
takes into account cluster membership. 
This is the natural tailoring of PCA to the 
case where the data are partitioned into 
labelled cohorts – an example from breast 
cancer proteomics is shown in Fig. 2 [18].
III. Pathway Modeling
The study of the cell functions is mod-
elled from experimental data sets which 
are both complex and dynamical [19], 
[20]. This has spawned the field of Sys-
tems Biology to understand and describe 
how molecular components interact to 
manifest the phenotypic behaviour 
which is the target of disease interven-
tion [21], illustrated in Fig. 3. In the sys-
tems biology literature there are two 
main classes of approaches:
Inverse problems, which involves  ❏
mining data from many perturbation 
experiments to identify a compatible 
structure of the signaling pathway.
Direct problems, to forecast and simu- ❏
late the forward evolution of dynami-
cal systems, using differential equations.
Several methods make the assump-
tion that the expression level of a given 
gene can be considered as a random 
variable and the mutual relationships 
between them can be derived by statisti-
cal dependencies. The resulting system is 
embedded in a probabilistic Graphical 
Model [22] described for example by a 
Bayesian Network [23], a Factor Graph 
[24], a Gaussian Graphical Model [25] 
or a Mutual Information derived Influ-
ence Network [26].
IV. Cancer Imaging 
Cancer imaging is a vast field focused 
on non-invasive measurement for 
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FIGURE 1 An illustration of meta-clustering. Each point on the map represents a clustering 
solution and close points represent similar solutions. Colors indicate a measure of quality for 
the solutions and red circles highlight local stability [15].
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 cancer detection, diagnosis and grading, 
and to monitor response to therapy by 
measuring tumor size and detecting re-
growth. Having started out as mainly 
anatomical measurement for anomaly 
detection as an indicator of malignancy, 
for instance using ultrasound and Mag-
netic Resonance Imaging (MRI), can-
cer imaging has developed into multiple 
modalities of physiological imaging 
including spectroscopy, with Magnetic 
Resonance Spectroscopy (MRS) and 
spatially localized Chemical Shift Imag-
es (CSI), with Positron-Emission 
Tomography (PET) and Single-Photon 
emission CT (SPECT) clinically widely 
used to measure glucose metabolism 
and therefore find regions with excep-
tionally high energetic rates, which are 
characteristic of tumor growth. An 
accessible review of machine learning 
applications to detection and diagnosis 
of disease may be found in [27].
A recent development is the use of 
specific functional imaging for tumor 
delineation, that is to say, to measure 
the contour during surgical planning 
and to identify tumor striations that 
may not be apparent clinically even 
during re-section. Initial efforts in this 
direction applied blind signal separation 
to single-voxel spectra to separate infil-
trating tumor mass compared with 
necrotic tissue [28]. However, tumors 
are not homogeneous, often mixing 
different types of tissue and sometimes 
with different grades of malignancy. 
One way to resolve this mixture is to 
segment the tumor composition, which 
is called nosological imaging, of which 
examples of diagnostic applications in 
brain are reported in [29], [30]. A relat-
ed and very important clinical area is 
follow-up imaging to determine tumor 
progression and to differentiate recur-
rent tumor growth from treatment-in-
duced tissue changes [31], [32].
V. Prognostic Outcome
Outcome modeling usually refers to 
the analysis of patterns of mortality and 
recurrence in longitudinal cohort stud-
ies, where a specific groups of patients 
followed-up for up to 20 years, record-
ing the occurrence of events of interest 
which may be cancer specific mortality, 
overall mortality or local and distal 
recurrence. The value of these studies is 
closely linked to the design of the fol-
low-up process, highlighting the need 
to involve biostatistical expertise from 
the very earliest stages in study design.
It is required to model the likeli-
hood of the event of interest, condi-
tional on the event not taking place at 
the start of the time interval and taking 
into account the loss of patients to fol-
low-up for reasons other than the event 
of interest, termed censorship. 
The application in medical statistics of 
linear-in-the-parameters models to non-
linear effects in outcome data generally 
involves discretising the data space to gen-
erate piecewise linear approximations to 
the desired response surfaces. However, 
this heuristic approach can have important 
consequences in cancer research, making 
it difficult to mine the hazard function for 
insights into the dynamics of metastatic 
spread [33] and inducing a categorisation 
of the histological grade of the tumor, 
which can give rise to important sub-
jective effects that impact on the choice 
of therapy given to the patient [34]. 
Neural network models fit non-lin-
ear, time dependent estimates of the 
hazard function, without the need to 
make proportionality assumptions or to 
discretize the state-space [35], [36] and 
their accuracy has been established by 
multi-centre, double-blind, evaluation 
[37] and this framework has recently 
been extended for estimating the joint 
model for more than one risk, e.g. local 
and distal recurrence [38].
VI. Conclusion 
Computational intelligence methodol-
ogy has been widely applied to data 
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FIGURE 2 Two views of cluster-based visualization of 25-d protein expression date from breast cancer histology showing (a) the HER-2 
positive cohort distinct from the rest and (b) rotating the 3-d view to illustrate the separation between the projections of the remaining 
seven clusters [18].
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mining in cancer but open questions 
remain before we can fully exploit the 
potential of molecular biology, to inte-
grate this into routine imaging and 
other non-invasive measurements for 
screening and early diagnosis, also to 
deliver consistency in laboratory mea-
surements especially in histopathology, 
and to more accurately model the bal-
ance between benefit and risk of thera-
py for niche groups of patients, down 
to the level of the individual. 
New data mining methods need to 
be developed to handle high-dimen-
sionality and large data volumes, to more 
efficiently model the dynamics of deep 
molecular pathways with high levels of 
noise and small experimental sample 
sizes, and also to robustly estimate haz-
ard functions with censored data with 
multiple competing risks. Analytical 
models need also to be integrated with 
clinical expert knowledge and processes, 
potentially by mapping into Boolean 
 filters [39].
The road ahead is long and bumpy. 
This article is provided as a sign-post to 
the nature of the key methodological 
and application challenges in this grow-
ing and exciting field.
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